Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026)
Phibro Animal Health (PAHC) posted quarterly Long-Term Deferred Tax of $15.3 million for Q1 2026, down 57.8% year-over-year from $36.2 million in Q1 2025, and down 21.74% quarter-over-quarter from $19.5 million in Q4 2025.
Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends
Phibro Animal Health's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $15.3 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 57.8% year-over-year to $15.3 million; the TTM figure through Mar 2026 stood at $15.3 million (down 57.8% YoY), while the FY2025 annual figure was $25.5 million, up 31.89% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $15.3 million, down from $19.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $36.2 million in Q1 2025, with the low at $4.1 million in Q1 2022.
- The 5-year median for Long-Term Deferred Tax is $14.5 million (2024), against an average of $16.1 million.
- The sharpest annual moves came in 2024 and 2026: Long-Term Deferred Tax surged 184.22% in 2024, then plunged 57.8% in 2026.
- Phibro Animal Health's Long-Term Deferred Tax stood at $6.3 million in 2022, then surged by 123.91% to $14.1 million in 2023, then soared by 139.16% to $33.8 million in 2024, then slumped by 42.29% to $19.5 million in 2025, then fell by 21.74% to $15.3 million in 2026.
- Business Quant data shows PAHC's Long-Term Deferred Tax at $15.3 million in Q1 2026, $19.5 million in Q4 2025, and $23.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.26 Mn |
| Dec 31, 2025 | 19.50 Mn |
| Sep 30, 2025 | 23.54 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Mar 31, 2025 | 36.17 Mn |
| Dec 31, 2024 | 33.80 Mn |
| Sep 30, 2024 | 25.53 Mn |
| Jun 30, 2024 | 19.37 Mn |
| Mar 31, 2024 | 14.51 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | 8.98 Mn |
| Jun 30, 2023 | 8.71 Mn |
| Mar 31, 2023 | 6.27 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 5.45 Mn |
| Jun 30, 2022 | 5.85 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 8.19 Mn |
| Sep 30, 2021 | 9.45 Mn |
| Jun 30, 2021 | 9.86 Mn |